ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Lupus"

  • Abstract Number: 2557 • 2013 ACR/ARHP Annual Meeting

    Fluctuations In sVCAM-1 and Adiponectin Mirror Fluctuations In Disease Activity In Lupus, But Cannot Be Use To Accurately Predict Impending Changes In Disease State

    Carolina landolt-Marticorena1, Stephenie Prokopec2, Stacey Morrison3, Heather Reich4, James Scholey4, Dafna D. Gladman5, Murray B. Urowitz5, Paul Boutros2, Paul R. Fortin6 and Joan E. Wither7, 1Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 2Ontario Institute for Cancer Research, Toronto, ON, Canada, 3Div Rheumatology Rm MP-10-304, The Toronto Western Hospital, Toronto, ON, Canada, 4Department of Medicine, The Toronto Western Hospital, Toronto, ON, Canada, 5Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 6University of Laval, Quebec, QC, Canada, 71E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Previous reports have identified a number of pro-inflammatory cyto/chemokines as candidate activity-specific SLE biomarkers.  In our preliminary studies we found that out of a…
  • Abstract Number: 1261 • 2013 ACR/ARHP Annual Meeting

    The Usefulness Of Traditional Neurocognitive Testing and N-Methyl-D-Aspartate Receptor Antibodies In Pediatric Lupus Patients

    Natasha M. Ruth1, Mary C. Kral2, Tamara K. Nowling3, Stephanie Slan4, Murray H. Passo5 and Gary S. Gilkeson4, 1Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, 2Genetics and Developmental Pediatrics, MUSC, Charleston, SC, 3Medicine/Rheumatology, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC, 4Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 5Pediatrics, Medical University of South Carolina, Charleston, SC

    Background/Purpose: In order to identify lupus patients at risk for CNS disease, and specifically, cognitive dysfunction, the ACR recommended a standard battery of tests for…
  • Abstract Number: 600 • 2013 ACR/ARHP Annual Meeting

    Factors Associated With Long-Term Renal Function Deterioration In Lupus Nephritis Treated Initially With Combined Prednisolone and Mycophenolate Mofetil (MMF) Or Tacrolimus (Tac)

    Chi Chiu Mok1, Chi Hung To1, King Yee Ying2, Cheuk-Wan Yim3 and Woon Leung Ng4, 1Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, 2Department of Medicine, Princess Margaret Hospital, Hong Kong, Hong Kong, 3Dept of Medicine, United Christian Hospital, Hong Kong, Hong Kong, 4Medicine, United Christian Hospital, Hong Kong, Hong Kong

    Background/Purpose: To study the risk factors for renal function decline in patients with lupus nephritis treated initially with combined steroid and MMF or Tac.Methods: Data…
  • Abstract Number: 2539 • 2013 ACR/ARHP Annual Meeting

    The Reliability Of a Novel Automated System For ANA Immunofluorescence Analysis In Daily Clinical Practice

    Mohammed Alsuwaidi1, Margit Dollinger1, Martin Fleck1,2 and Boris P. Ehrenstein1, 1Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, Bad Abbach, Germany, 2Internal Medicine I, University Medical Center of Regensburg, Regensburg, Germany

    Background/Purpose:  Recently, automated interpretation (AI) systems for anti-nuclear antibody (ANA) analysis have been introduced based on assessment of indirect immunofluorescence (IIF) patterns. However, the reliability…
  • Abstract Number: 1063 • 2013 ACR/ARHP Annual Meeting

    The Influence Of Socioeconomic and Race In Damage Score In Patients With Systemic Lupus Erythematosus

    Roberto Teixeira1, Eduardo F. Borba2, Georges Christopoulos Sr.3 and Emilia Sato4, 1UNIVERSIDADE FEDERAL DE SÃO PAULO, SAO PAULO, Brazil, 2Rheumatology Division; University of São Paulo, São Paulo, Brazil, 3SANTA CASA DE MISERICORDIA DE MACEIO, MACEIO, Brazil, 4Medicina, Universidade Federal de São Paulo, São Paulo, Brazil

    Background/Purpose: The association between socioeconomic status and damage in Systemic lupus erythematosus patients is confounded by the influence of race in various previous studies.  The…
  • Abstract Number: 564 • 2013 ACR/ARHP Annual Meeting

    Role of TLR3 and dsRNA Hyper-Responsiveness in the Generation of the Lupus-Like Phenotype of New Zealand Black Congenic Mice

    Gillian Minty1, Nan-Hua Chang2, Kieran Manion3, Yuriy Baglaenko1, Evelyn Pau4 and Joan E. Wither5, 1Immunology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 2Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 3Immunology, University of Toronto, Toronto, ON, Canada, 4Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 51E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

    Background/Purpose: New Zealand Black (NZB) mice develop a spontaneous lupus-like autoimmune disease, similar to human systemic lupus erythematosus. Genetic mapping studies have linked loci on…
  • Abstract Number: 2523 • 2013 ACR/ARHP Annual Meeting

    Inflammatory Arthritis Activity During Pregnancy In Systemic Lupus Erythematosus

    Sara K. Tedeschi, Bonnie L. Bermas and Karen H. Costenbader, Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: While overall SLE disease and lupus nephritis activity during pregnancy have been studied, the activity of inflammatory arthritis during SLE pregnancy has not been…
  • Abstract Number: 1064 • 2013 ACR/ARHP Annual Meeting

    Trends In Hospitalizations Due To Organ Damage In Patients With Systemic Lupus Erythematosus In Canada, 2006-2010

    Amyn Sayani1, Neerav Monga2, Marni Freeman2 and Jorge Alfonso Ross Terres3, 1Medical Affairs, GlaxoSmithKline, Mississauga, ON, Canada, 2Health Economics and Outcomes Research, Medical Division, GlaxoSmithKline, Inc., Mississauga, ON, Canada, 3Medical Affairs, GlaxoSmithKline, Inc., Mississauga, ON, Canada

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect multiple organs in the body, including the heart, kidney and lung, leading to…
  • Abstract Number: 568 • 2013 ACR/ARHP Annual Meeting

    Pneumococcal Polysaccharide Vaccination Regulates T and B Lymphocyte Cytokine Responses and Decreases Kidney Stat1 Levels In MRL/Lpr Mice In Vivo

    Victor Gazivoda1, Shikha Mehta2, Luhan Wang3, Julia Ash4, Kirk E. Sperber3 and Ioannis Tassiulas3, 1Medicine, New York Medical College, Valhalla, NY, 2New York Medical College, Valhalla, NY, 3Medicine-Rheumatology, New York Medical College, Valhalla, NY, 4Rheumatology, New York Medical College, Valhalla, NY

    Background/Purpose: Zwitterionic polysaccharides can activate CD4+ T cells after processing and presentation by antigen-presenting cells. The 23-valent capsular polysaccharide pneumococcal vaccine, PneumoVax, protects against invasive…
  • Abstract Number: 2521 • 2013 ACR/ARHP Annual Meeting

    Correlation Of Anti Single and Double Stranded DNA Antibodies and Disease Activity In Systemic Lupus Erythematosus

    Cecilia Catoggio, Cecilia Reimundes and Carlos Edgardo Perandones, Rheumatology and Immunology, CEMIC, Buenos Aires, Argentina

    Background/Purpose: Anti DNA antibodies are considered a hallmark of systemic lupus erythematosus (SLE).  Anti double stranded DNA antibody (dsDNA) is part of the SLE classification…
  • Abstract Number: 1069 • 2013 ACR/ARHP Annual Meeting

    Racial Differences In Systemic Lupus Erythematosus Patients’ Treatment Preferences: A Two-Site Study

    Ernest R. Vina1, Tammy O. Utset2, Michael J. Hannon3, Nicole Roberts4, Christopher M. Masi5 and C. Kent Kwoh6, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh and VA Pittsburgh Healthcare System, Pittsburgh, PA, 2Rheumatology, University of Chicago Medical Center, Chicago, IL, 3Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 4Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 5Internal Medicine, NorthShore University Health System, Evanston, IL, 6School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Racial disparities in systemic lupus erythematosus (SLE) exist, with African-American (AA) patients experiencing higher lupus damage scores and disease activity than white (WH) patients. …
  • Abstract Number: 545 • 2013 ACR/ARHP Annual Meeting

    Preferential Infiltration Of Double-Negative (DN) T Cells Into The Glomeruli Of NZM 2328 Lupus Mice

    Ning Yu, Shunhua Guo, William Stohl and Chaim O. Jacob, Division of Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA

    Background/Purpose: Lupus nephritis affects at least 50% of patients with SLE and is a major cause of morbidity. The pathologic picture of lupus nephritis is…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology